Compare · DGX vs ELV
DGX vs ELV
Side-by-side comparison of Quest Diagnostics Incorporated (DGX) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DGX and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $90.24B, about 4.1x DGX ($22.17B).
- DGX has been more active in the news (13 items in the past 4 weeks vs 3 for ELV).
- DGX has more recent analyst coverage (25 ratings vs 23 for ELV).
- Company
- Quest Diagnostics Incorporated
- Elevance Health Inc.
- Price
- $200.30+2.06%
- $415.68+1.52%
- Market cap
- $22.17B
- $90.24B
- 1M return
- -
- +10.97%
- 1Y return
- -
- +6.68%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 13
- 3
- Recent ratings
- 25
- 23
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest DGX
- CEO and President Davis J. E. sold $1,941,400 worth of shares (10,000 units at $194.14) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 132,423 units (SEC Form 4)
- Director Carter Robert B was granted 1,142 shares, increasing direct ownership by 42% to 3,853 units (SEC Form 4)
- Director Gregg Vicky B was granted 1,142 shares, increasing direct ownership by 7% to 18,314 units (SEC Form 4)
- Director Main Timothy L was granted 1,142 shares, increasing direct ownership by 4% to 27,439 units (SEC Form 4)
- Director Diaz Luis was granted 1,142 shares, increasing direct ownership by 28% to 5,196 units (SEC Form 4)
- Director Wentworth Timothy C was granted 1,142 shares, increasing direct ownership by 529% to 1,358 units (SEC Form 4)
- Director Doi Tracey was granted 1,142 shares, increasing direct ownership by 17% to 7,748 units (SEC Form 4)
- Director Ring Timothy M was granted 1,142 shares, increasing direct ownership by 4% to 31,140 units (SEC Form 4)
- Director Lassiter Wright Iii was granted 1,142 shares, increasing direct ownership by 12% to 10,317 units (SEC Form 4)
- Director Morrison Denise M was granted 1,142 shares, increasing direct ownership by 11% to 11,929 units (SEC Form 4)
Latest ELV
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)
- Director Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)